| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9954 | 
      | Human Intestinal Absorption | HIA- | 0.9112 | 
      | Caco-2 Permeability | Caco2- | 0.7812 | 
      | P-glycoprotein Substrate | Substrate | 0.5274 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9447 | 
                                                     | Non-inhibitor | 0.9872 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9620 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.4474 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7684 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8611 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5946 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8778 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9259 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9350 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9206 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8921 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9761 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9997 | 
                                                                    | Non-inhibitor | 0.9091 | 
      | AMES Toxicity | Non AMES toxic | 0.8884 | 
      | Carcinogens | Non-carcinogens | 0.6178 | 
      | Fish Toxicity | High FHMT | 0.9443 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.8432 | 
      | Honey Bee Toxicity | Low HBT | 0.7087 | 
      | Biodegradation | Not ready biodegradable | 0.9760 | 
      | Acute Oral Toxicity | IV | 0.6502 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6952 |